Furthermore, we observed that a monoclonal anti-JAM-C antibody decreased the severity of mouse antigen-induced arthritis (AIA) and delayed the onset of K/BxN serum transfer-induced arthritis. The gene discussed is JAM3; the disease is arthritic joint disease.